This resolution directs the President to furnish to the House of Representatives any documents or communications relating to the recall of infant formula manufactured by Abbott Laboratories, particularly communications involving the Food and Drug Administration.
Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to the recall of infant formula manufactured by Abbott Laboratories and potential impacts on the infant formula supply chain.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary reported to house (Sep 30, 2022)
This resolution directs the President to furnish to the House of Representatives any documents or communications relating to the recall of infant formula manufactured by Abbott Laboratories, particularly communications involving the Food and Drug Administration.
What just happenedSep 30, 2022
Placed on the House Calendar, Calendar No. 144.
Who’s behind it
- Reported in HouseSep 30, 2022
- Introduced in HouseJul 26, 2022
- Sep 30, 2022CalendarsH12420
Placed on the House Calendar, Calendar No. 144.
- Sep 30, 2022CommitteeH12200
Reported by the Committee on Energy and Commerce. H. Rept. 117-538.
Energy and Commerce Committee - Sep 30, 2022Committee5000
Reported by the Committee on Energy and Commerce. H. Rept. 117-538.
Energy and Commerce Committee - Sep 21, 2022Committee
Subcommittee on Health Discharged.
Energy and Commerce Committee - Sep 21, 2022Committee
Ordered to be Reported by the Yeas and Nays: 54 - 0.
Energy and Commerce Committee - Sep 21, 2022Committee
Committee Consideration and Mark-up Session Held.
Energy and Commerce Committee - Jul 27, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 26, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jul 26, 2022IntroReferralIntro-H
Introduced in House
- Jul 26, 2022IntroReferral1000
Introduced in House
This resolution directs the President to furnish to the House of Representatives any documents or communications relating to the recall of infant formula manufactured by Abbott Laboratories, particularly communications involving the Food and Drug Administration.